Year: 2012
Type: article
Source: Nature Biotechnology
DOI: 10.1038/nbt.2153
Authors: David Adams, Lucia Altucci, Stylianos E Antonarakis, Juan Ballesteros, Stephan Beck, Adrian Bird, Christoph Bock, Bernhard Boehm, Elias Campo, Andrea Caricasole, Fredrik Dahl, Emmanouil T Dermitzakis, Tariq Enver, Manel Esteller, Xavier Estivill, Anne Ferguson-Smith, Jude Fitzgibbon, Paul Flicek, Claudia Giehl, Thomas Graf, Frank Grosveld, Roderic Guigo, Ivo Gut, Kristian Helin, Jonas Jarvius, Ralf Küppers, Hans Lehrach, Thomas Lengauer, Åke Lernmark, David Leslie, Markus Loeffler, Elizabeth Macintyre, Antonello Mai, Joost HA Martens, Saverio Minucci, Willem H Ouwehand, Pier Giuseppe Pelicci, Hèléne Pendeville, Bo Porse, Vardhman Rakyan, Wolf Reik, Martin Schrappe, Dirk Schübeler, Martin Seifert, Reiner Siebert, David Simmons, Nicole Soranzo, Salvatore Spicuglia, Michael Stratton, Hendrik G Stunnenberg, Amos Tanay, David Torrents, Alfonso Valencia, Edo Vellenga, Martin Vingron, Jörn Walter, Spike Willcocks
Institutions: Wellcome Sanger Institute, University of Campania "Luigi Vanvitelli", University of Geneva, University College London, University of Edinburgh, Max Planck Institute for Informatics, Universität Ulm, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Siena Biotech (Italy), Institut d'Investigació Biomédica de Bellvitge, Centre for Genomic Regulation, University of Cambridge, Queen Mary University of London, European Bioinformatics Institute, European Research and Project Office, Erasmus MC, Centro Nacional de Análisis Genómico, University of Copenhagen, Sigolis (Sweden), Essen University Hospital, Max Planck Institute for Molecular Genetics, Lund University, Leipzig University, Centre National de la Recherche Scientifique, Université Paris Descartes, Sapienza University of Rome, Radboud University Nijmegen, European Institute of Oncology, Diagenode (Belgium), Babraham Institute, Friedrich Miescher Institute, Christian-Albrechts-Universität zu Kiel, Inserm, Weizmann Institute of Science, Barcelona Supercomputing Center, Spanish National Cancer Research Centre, University Medical Center Groningen, Saarland University, Oxford Nanopore Technologies (United Kingdom)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Funders: Queen Mary University of London, Wellcome Trust, Cancer Research UK, Radboud Universiteit, Lunds Universitet, Sapienza Università di Roma, Centre National de la Recherche Scientifique, Université Paris Descartes, Medical Research Council, Biotechnology and Biological Sciences Research Council
OpenAlex ID: W2063322714
